U.S. flag

An official website of the United States government

Format
Items per page
Sort by

Send to:

Choose Destination

Links from GEO DataSets

Items: 20

1.

Differentially expressed genes after miRNA or siRNA transfection in human cancer cell lines (A-498, 786-O, A549, TE-8, PANC-1, SW1990, PC3 and PC3M)

(Submitter supplied) To identify differentially expressed genes by anti cancer treatments (microRNAs or siRNAs) in human cancer, several cell lines ( renal cell carcinoma, lung adenocarcinoma, esophageal, pancreatic and prostate cancer) were subjected to Agilent whole genome microarrays.
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL20844
16 Samples
Download data: TXT
Series
Accession:
GSE93290
ID:
200093290
2.

Whole-Tissue Gene Expression Study of Pancreatic Ductal Adenocarcinoma

(Submitter supplied) Expression analysis of 36 pancreatic ductal adenocarcinoma tumors and matching normal pancreatic tissue samples from pancreatic cancer patients of the Clinical Institute Fundeni (ICF) using Affymetrix U133 Plus 2.0 whole-genome chips.
Organism:
Homo sapiens
Type:
Expression profiling by array
Dataset:
GDS4103
Platform:
GPL570
78 Samples
Download data: CEL
Series
Accession:
GSE15471
ID:
200015471
3.
Full record GDS4103

ICF cohort: Whole-tissue pancreatic ductal adenocarcinoma

Analysis of pancreatic ductal adenocarcinoma (PDAC) tumors and matching normal pancreatic tissue from ICF pancreatic cancer patients. PDAC is an aggressive, rapidly disseminating, desmoplastic cancer with poor prognosis. Results provide insight into molecular processes involved in PDAC pathology.
Organism:
Homo sapiens
Type:
Expression profiling by array, transformed count, 36 individual, 2 tissue sets
Platform:
GPL570
Series:
GSE15471
78 Samples
Download data: CEL
4.

Differentially expressed genes after miRNA or siRNA transfection in human cancer cell lines (SK-MES, MDA-MB-231, MKN and 786-O)

(Submitter supplied) To identify differentially expressed genes by anti cancer treatments (microRNAs or siRNAs) in human cancer, several cell lines (lung cancer, breast cancer, gastric cancer and renal cancer) were subjected to Agilent whole genome microarrays.
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL20844
8 Samples
Download data: TXT
Series
Accession:
GSE113066
ID:
200113066
5.

Differentially expressed genes in human brest cancer specimens

(Submitter supplied) To identify differentially expressed genes in human brest cancer specimens were subjected to Agilent whole genome microarrays.
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL20844
4 Samples
Download data: TXT
Series
Accession:
GSE118539
ID:
200118539
6.

Differentially expressed genes after miRNA or siRNA transfection in human cancer cell lines (III)

(Submitter supplied) To identify differentially expressed genes by anti cancer treatments (microRNAs or siRNAs) in human cancer, several cell lines (pancreatic cancer, esophageal cancer, tongue squamous cell carcinoma, hypopharyngeal squamous cell carcinoma and lung squamous cell carcinoma) were subjected to Agilent whole genome microarrays.
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL20844
16 Samples
Download data: TXT
Series
Accession:
GSE82108
ID:
200082108
7.

Differentially expressed genes after miRNA or siRNA transfection in human cancer cell lines II

(Submitter supplied) To identify differentially expressed genes by anti cancer treatments (microRNAs or siRNAs) in human cancer, several cell lines (pancreatic cancer, esophageal cancer, bladder cancer, prostate cancer, renal cell carcinoma and lung squamous cell carcinoma) were subjected to Agilent whole genome microarrays.
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL20844
32 Samples
Download data: TXT, XLSX
Series
Accession:
GSE77790
ID:
200077790
8.

Differentially expressed genes after miRNA or siRNA transfection in human cancer cell lines (II)

(Submitter supplied) To identify differentially expressed genes by anti cancer treatments (microRNAs or siRNAs) in human cancer, several cell lines (bladder cancer, prostate cancer, renal cell carcinoma, oral squamous cell carcinoma and lung squamous cell carcinoma) were subjected to Agilent whole genome microarrays.
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL16699
32 Samples
Download data: TXT
Series
Accession:
GSE66498
ID:
200066498
9.

Differentially expressed genes in HNSCC tissues, normal oral epithelial tissues and CAFs

(Submitter supplied) To identify differentially expressed genes by HNSCC tissues, normal oral epithelial tissues and CAFs were subjected to Agilent whole genome microarrays.
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL21185
8 Samples
Download data: TXT, XLSX
Series
Accession:
GSE172120
ID:
200172120
10.

Differentially expressed genes after miRNA or siRNA transfection in human cancer cell lines IV

(Submitter supplied) To identify differentially expressed genes by anti cancer treatments (microRNAs or siRNAs) in human cancer, several cell lines (pancreatic cancer, esophageal cancer and lung squamous cell carcinoma) were subjected to Agilent whole genome microarrays.
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL20844
8 Samples
Download data: TXT
Series
Accession:
GSE107008
ID:
200107008
11.

Differentially expressed genes after miRNA or siRNA transfection in multiple human cancer cell lines

(Submitter supplied) To identify differentially expressed genes by anti cancer treatments (microRNAs or siRNAs) in human cancer, several cell lines ( pancreatic cancer, renal cell carcinoma, oral squamous cell carcinoma, prostate cancer and bladder cancer) were subjected to Agilent whole genome microarrays.
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL20844
16 Samples
Download data: TXT
Series
Accession:
GSE106791
ID:
200106791
12.

Differentially expressed genes after miRNA or siRNA transfection in human cancer cell lines Panc-1, FaDu and PC3

(Submitter supplied) To identify differentially expressed genes by anti cancer treatments (microRNAs or siRNAs) in human cancer, several cell lines (pancreatic cancer, hypopharyngeal squamous cell carcinoma and prostate cancer) were subjected to Agilent whole genome microarrays.
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL20844
8 Samples
Download data: TXT
Series
Accession:
GSE85614
ID:
200085614
13.

Identification of target genes of cancer-related microRNAs in human cancer

(Submitter supplied) To identify target genes of cancer-related microRNAs in human cancer, several cell lines (bladder cancer, prostate cancer, renal cell carcinoma, esophageal squamous cell carcinoma, and head and neck squamous cell carcinoma) were subjected to Agilent whole genome microarrays.
Organism:
Homo sapiens
Type:
Expression profiling by array
Platforms:
GPL13607 GPL10332
35 Samples
Download data: TXT
Series
Accession:
GSE37119
ID:
200037119
14.

Differentially expressed genes after siRNA transfection in human cancer cell lines

(Submitter supplied) To identify differentially expressed genes by anti cancer treatments (siRNAs) in human cancer, several cell lines (lung cancer, breast cancer and pancreatic cancer) were subjected to Agilent whole genome microarrays.
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL20844
8 Samples
Download data: TXT
Series
Accession:
GSE115909
ID:
200115909
15.

Differentially expressed genes after miRNA or siRNA transfection in human cancer cell lines III

(Submitter supplied) To identify differentially expressed genes by anti cancer treatments (microRNAs or siRNAs) in human cancer, several cell lines ( pancreatic cancer, renal cell carcinoma, oral squamous cell carcinoma, prostate cancer and bladder cancer) were subjected to Agilent whole genome microarrays.
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL20844
8 Samples
Download data: TXT
Series
Accession:
GSE115801
ID:
200115801
16.

microRNA modulated networks of adaptive and innate immune response in pancreatic ductal adenocarcinoma

(Submitter supplied) Despite progress in treatment strategies, only ~24% of pancreatic ductal adenocarcinoma (PDAC) patients survive >1 year. Our goal was to elucidate deregulated pathways modulated by microRNAs (miRNAs) in PDAC and Vater ampulla (AMP) cancers.
Organism:
synthetic construct; Homo sapiens
Type:
Non-coding RNA profiling by array
Platform:
GPL19117
28 Samples
Download data: CEL, CHP
Series
Accession:
GSE125179
ID:
200125179
17.

Differentially expressed genes after miRNA or siRNA transfection in human cancer cell lines (T24, BOY, A549 and SK-MES)

(Submitter supplied) To identify differentially expressed genes by anti cancer treatments (microRNAs or siRNAs) in human cancer, several cell lines (pancreatic cancer, esophageal cancer and lung squamous cell carcinoma) were subjected to Agilent whole genome microarrays.
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL20844
8 Samples
Download data: TXT
Series
Accession:
GSE123318
ID:
200123318
18.

Global mRNA/LncRNA expression analysis of pancreatic tumors causing type3C Diabetes Mellitus

(Submitter supplied) Pancreatic tumors with small size can cause type3C Diabetes Mellitus (PCA-DM) but the mechanism is unknown. In this study we aimed at revealing the mRNA and long noncoding RNA (LncRNA) expression patterns of pancreatic tumors that triggered PCA-DM. Four pancreatic tumors from patients with PCA-DM (A1-A4), four pancreatic tumors from patients without PCA-DM (B1-B4), and four pancreatic tissues from patients with pancreatitis were individually profiled with Agilent microarrays(Arraystar Human LncRNA Array v3.0).
Organism:
Homo sapiens
Type:
Expression profiling by array; Non-coding RNA profiling by array
Platform:
GPL16956
12 Samples
Download data: TXT
Series
Accession:
GSE61166
ID:
200061166
19.

microRNA expression changes after knocking out MYEOV in two human pancreatic cancer cell lines

(Submitter supplied) Pancreatic cancer (PC) remains a highly lethal malignancy worldwide. As metastasis and malignant proliferation are primarily responsible for poor clinical outcomes of PC, it is imminent to dig out the pivotal gene involved in the process as well as its underlying molecular mechanism. In this study, through analysis of TCGA and GTEx data, we found that the expression level of MYEOV was obviously increased in carcinoma tissues relative to healthy ones and associated with poor survival in PC patients. more...
Organism:
Homo sapiens
Type:
Non-coding RNA profiling by high throughput sequencing
Platform:
GPL11154
12 Samples
Download data: TXT
Series
Accession:
GSE143828
ID:
200143828
20.

Genome-wide analysis of gene expression patterns in human kidney cancer

(Submitter supplied) This SuperSeries is composed of the SubSeries listed below.
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL570
54 Samples
Download data: CEL
Series
Accession:
GSE66272
ID:
200066272
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

db=gds|term=|query=9|qty=3|blobid=MCID_668e601349fc8a2325b4553b|ismultiple=true|min_list=5|max_list=20|def_tree=20|def_list=|def_view=|url=/Taxonomy/backend/subset.cgi?|trace_url=/stat?
   Taxonomic Groups  [List]
Tree placeholder
    Top Organisms  [Tree]

Find related data

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Support Center